Keyphrases
Genetic Interaction
100%
Bladder Cancer Risk
100%
SNP-SNP Interaction
83%
Polygenic Risk Score
50%
Bladder Cancer Diagnosis
33%
Non-Caucasian
33%
High Risk
16%
Cox Proportional Hazards Model
16%
Genetic Variation
16%
Risky Driving
16%
Negatively Associated
16%
SNP
16%
Bonferroni Correction
16%
Bladder Cancer
16%
Genome-wide SNPs
16%
Score-based
16%
Machine Learning Approach
16%
Screening Model
16%
Risk Score Model
16%
UK Biobank
16%
Early Manifestation
16%
Bladder Tumorigenesis
16%
Integrated Interactions
16%
Rbfox3
16%
ST7L
16%
Fhit
16%
LARP4B
16%
GenEpi
16%
Medicine and Dentistry
Cancer Risk
100%
Single Nucleotide Polymorphism
100%
Bladder Cancer
100%
Gene Interaction
100%
Cancer Screening
18%
Genome Wide Association Study
9%
Proportional Hazards Model
9%
Genetic Variation
9%
Carcinogenesis
9%
Bladder
9%
Chromosome 17
9%
UK Biobank
9%
Biochemistry, Genetics and Molecular Biology
Single Nucleotide Polymorphism
100%
Gene Interaction
100%
Polygenic Score
27%
Cancer Screening
18%
Genetic Divergence
9%
Genome Wide Association Study
9%
FHIT
9%
Genetic Variation
9%
Chromosome 17
9%
Carcinogenesis
9%
Immunology and Microbiology
Single Nucleotide Polymorphism
100%
Gene Interaction
100%
Cancer Screening
18%
Genetic Variation
9%
Chromosome 17
9%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Carcinogenesis
11%